Company record
Reliance Life Sciences Private Limited
1 FDA warning letter since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Reliance Life Sciences Private Limited.
Warning letters
-
DrugsReliance Life Sciences Private Limited
FDA warned India's Reliance Life Sciences over falsified microbiology records and aseptic failures in sterile drug production, prompting a recall.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 15 | Class II | Reliance Life Sciences Private Limited Drug |
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01 Lack of Sterility Assurance |
| Jul 15 | Class II | Reliance Life Sciences Private Limited Drug |
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01 Lack of Sterility Assurance |
| Jul 15 | Class II | Reliance Life Sciences Private Limited Drug |
Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01 Lack of Sterility Assurance |
| Jul 15 | Class II | Reliance Life Sciences Private Limited Drug |
Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01 Lack of Sterility Assurance |